Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05740553 · ClinicalTrials.gov registry record · NA
Automated Stereognosis to Treat Loss of Tactile Function After Brain Injury
A NA study, sponsored by The University of Texas at Dallas.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT05740553: Clinical Trial NA study, sponsored by The University of Texas at Dallas.
NCT05740553 is a NA study that was terminated before completion, run by The University of Texas at Dallas. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05740553, a NA study, was terminated before completion, sponsored by The University of Texas at Dallas.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
Researchers aim to determine whether the ReTrieve system for tactile training can improve tactile function (sense of touch) in the hand after brain injury when used at home for 6 weeks.
Primary Outcome
The majority of participants should manage at least 4500 retrievals over their \~30 hours of system use
Interventions
- DEVICE ReTrieve Automated Stereognosis System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2022-06-06 |
| Phase | NA |
Why NCT05740553 stopped before completion
NCT05740553 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which ReTrieve Automated Stereognosis System is the first listed.
NCT05740553 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05740553 about?
NCT05740553 is a clinical study titled "Automated Stereognosis to Treat Loss of Tactile Function After Brain Injury". Researchers aim to determine whether the ReTrieve system for tactile training can improve tactile function (sense of touch) in the hand after brain injury when used at home for 6 weeks.
What is the current status of trial NCT05740553?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2021-11-15. Estimated completion is 2022-06-06.
What interventions are being tested in trial NCT05740553?
The interventions under investigation include: ReTrieve Automated Stereognosis System (DEVICE).
Who is sponsoring clinical trial NCT05740553?
This trial is sponsored by The University of Texas at Dallas, which has 50 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05740553's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI